Northern Trust Corp Repare Therapeutics Inc. Transaction History

Northern Trust Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.16 - $13.01 $60,702 - $96,781	-7,439 Reduced 33.59%	14,710 $177,000
Q2 2023 Aug 11, 2023	SELL	$8.63 - $12.53 $474 - $689	-55 Reduced 0.25%	22,149 $234,000
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $6,924 - $11,189	-743 Reduced 3.24%	22,204 $218,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $18.13 $13,075 - $18,963	1,046 Added 4.78%	22,947 $337,000
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $7,265 - $9,790	628 Added 2.95%	21,901 $265,000
Q2 2022 Aug 12, 2022	BUY	$8.45 - $14.84 $5,484 - $9,631	649 Added 3.15%	21,273 $298,000
Q1 2022 May 13, 2022	SELL	$11.38 - $21.88 $4,176 - $8,029	-367 Reduced 1.75%	20,624 $294,000
Q4 2021 Feb 08, 2022	BUY	$19.66 - $28.11 $101,465 - $145,075	5,161 Added 32.6%	20,991 $442,000
Q3 2021 Nov 15, 2021	BUY	$25.71 - $35.24 $5,990 - $8,210	233 Added 1.49%	15,830 $415,000
Q2 2021 Aug 13, 2021	BUY	$30.1 - $34.85 $469,469 - $543,555	15,597 New	15,597 $487,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.